{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:37:07Z","timestamp":1789763827729,"version":"4.0.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["NRF-2022R1A2C1092597"],"award-info":[{"award-number":["NRF-2022R1A2C1092597"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["NRF-2019R1A5A2026045"],"award-info":[{"award-number":["NRF-2019R1A5A2026045"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020206","name":"Korea Dementia Research Center","doi-asserted-by":"publisher","award":["RS-2024-00338662"],"award-info":[{"award-number":["RS-2024-00338662"]}],"id":[{"id":"10.13039\/100020206","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.phrs.2024.107432","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T09:09:06Z","timestamp":1727082546000},"page":"107432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["GPR40 agonist ameliorates neurodegeneration and motor impairment by regulating NLRP3 inflammasome in Parkinson\u2019s disease animal models"],"prefix":"10.1016","volume":"209","author":[{"given":"Tae-Young","family":"Ha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Bong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeji","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Myun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keun-A","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2024.107432_bib1","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"18","key":"10.1016\/j.phrs.2024.107432_bib2","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1212\/01.wnl.0000275524.15125.f4","article-title":"alpha-Synuclein and Parkinson disease susceptibility","volume":"69","author":"Winkler","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.phrs.2024.107432_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13024-019-0332-6","article-title":"Impaired dopamine metabolism in Parkinson's disease pathogenesis","volume":"14","author":"Masato","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"18","key":"10.1016\/j.phrs.2024.107432_bib4","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1016\/j.bmcl.2017.07.075","article-title":"Current approaches to the treatment of Parkinson's Disease","volume":"27","author":"Ellis","year":"2017","journal-title":"Bioorg. Med Chem. Lett."},{"issue":"4","key":"10.1016\/j.phrs.2024.107432_bib5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2147\/NDT.S2006","article-title":"and L.G. Aguilar, Current approaches to the treatment of Parkinson's disease.","volume":"4","author":"Jankovic","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"Suppl 1","key":"10.1016\/j.phrs.2024.107432_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/jnc.13750","article-title":"Current and experimental treatments of Parkinson disease: a guide for neuroscientists","volume":"139","author":"Oertel","year":"2016","journal-title":"J. Neurochem"},{"issue":"16","key":"10.1016\/j.phrs.2024.107432_bib7","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological treatment of Parkinson disease: a review","volume":"311","author":"Connolly","year":"2014","journal-title":"Jama"},{"issue":"6","key":"10.1016\/j.phrs.2024.107432_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065792","article-title":"Neuroinflammation in Parkinson's disease: from gene to clinic: a systematic review","volume":"24","author":"Castillo-Rangel","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2024.107432_bib9","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0022-2275(20)37235-7","article-title":"Age-related changes in phospholipid fatty acid composition and monoaminergic neurotransmission in the hippocampus of rats fed a balanced or an n-3 polyunsaturated fatty acid-deficient diet","volume":"38","author":"Delion","year":"1997","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.phrs.2024.107432_bib10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0197-4580(00)00170-6","article-title":"Age-related changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus","volume":"21","author":"Favrel\u00e8re","year":"2000","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.phrs.2024.107432_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-4159.1989.tb09133.x","article-title":"Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease","volume":"52","author":"Dexter","year":"1989","journal-title":"J. Neurochem"},{"key":"10.1016\/j.phrs.2024.107432_bib12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainres.2011.11.012","article-title":"Involvement of the long-chain fatty acid receptor GPR40 as a novel pain regulatory system","volume":"1432","author":"Nakamoto","year":"2012","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.phrs.2024.107432_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112625","article-title":"Involvement of G-protein-coupled receptor 40 in the inhibitory effects of docosahexaenoic acid on SREBP1-mediated lipogenic enzyme expression in primary hepatocytes","volume":"20","author":"On","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2024.107432_bib14","article-title":"Effect of marine-derived n-3 polyunsaturated fatty acids on C-reactive protein, interleukin 6 and tumor necrosis factor \u03b1: a meta-analysis","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2024.107432_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109104","article-title":"Efficacy of the omega-3 fatty acids supplementation on inflammatory biomarkers: an umbrella meta-analysis","volume":"111","author":"Kavyani","year":"2022","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107432_bib16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/1028415X.2020.1735143","article-title":"Potential treatment of Parkinson's disease with omega-3 polyunsaturated fatty acids","volume":"25","author":"Li","year":"2022","journal-title":"Nutr. Neurosci."},{"issue":"Pt B)","key":"10.1016\/j.phrs.2024.107432_bib17","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neuropharm.2015.05.013","article-title":"The role of polyunsaturated fatty acids and GPR40 receptor in brain","volume":"113","author":"Khan","year":"2017","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.phrs.2024.107432_bib18","first-page":"303","article-title":"Best practices for generating and using alpha-synuclein pre-formed fibrils to model Parkinson's disease in rodents","volume":"8","author":"Polinski","year":"2018","journal-title":"J. Park. Dis."},{"issue":"148","key":"10.1016\/j.phrs.2024.107432_bib19","doi-asserted-by":"crossref","DOI":"10.3791\/59758-v","article-title":"Generation of alpha-synuclein preformed fibrils from monomers and use in vivo","author":"Patterson","year":"2019","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.phrs.2024.107432_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.902077","article-title":"Quiescent elongation of \u03b1-synuclein pre-form fibrils under different solution conditions","volume":"16","author":"Mao","year":"2022","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2024.107432_bib21","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1007\/s10916-011-9737-7","article-title":"Image analysis tools for evaluation of microscopic views of immunohistochemically stained specimen in medical research-a review","volume":"36","author":"Prasad","year":"2012","journal-title":"J. Med. Syst."},{"issue":"1","key":"10.1016\/j.phrs.2024.107432_bib22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.phrs.2024.107432_bib23","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/hipo.22263","article-title":"GPR40 activation leads to CREB and ERK phosphorylation in primary cultures of neurons from the mouse CNS and in human neuroblastoma cells","volume":"24","author":"Zamarbide","year":"2014","journal-title":"Hippocampus"},{"issue":"3-4","key":"10.1016\/j.phrs.2024.107432_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03033565","article-title":"The 6-hydroxydopamine model of Parkinson's disease","volume":"11","author":"Simola","year":"2007","journal-title":"Neurotox. Res"},{"issue":"1","key":"10.1016\/j.phrs.2024.107432_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1471-4159.2007.04699.x","article-title":"Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons","volume":"103","author":"Rodriguez-Pallares","year":"2007","journal-title":"J. Neurochem"},{"issue":"3","key":"10.1016\/j.phrs.2024.107432_bib26","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1471-4159.2009.06189.x","article-title":"Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease","volume":"110","author":"Marinova-Mutafchieva","year":"2009","journal-title":"J. Neurochem"},{"key":"10.1016\/j.phrs.2024.107432_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/387028","article-title":"Striatal Injury with 6-OHDA transiently increases cerebrospinal GFAP and S100B","volume":"2015","author":"Batassini","year":"2015","journal-title":"Neural Plast."},{"issue":"2","key":"10.1016\/j.phrs.2024.107432_bib28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00441-010-1061-x","article-title":"Effect of 6-hydroxydopamine (6-OHDA) on proliferation of glial cells in the rat cortex and striatum: evidence for de-differentiation of resident astrocytes","volume":"342","author":"Wachter","year":"2010","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.phrs.2024.107432_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104623","article-title":"Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: involvement of retrograde and anterograde axonal propagation","volume":"134","author":"Mezias","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2024.107432_bib30","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1038\/s41467-020-18689-x","article-title":"CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson's disease","volume":"11","author":"Bengoa-Vergniory","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2024.107432_bib31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12974-019-1636-8","article-title":"Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice","volume":"16","author":"Earls","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2024.107432_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fnint.2021.715190","article-title":"Temporal evolution of inflammation and neurodegeneration with alpha-synuclein propagation in Parkinson's disease mouse model","volume":"15","author":"Lai","year":"2021","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.phrs.2024.107432_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120127","article-title":"GPR40 agonist inhibits NLRP3 inflammasome activation via modulation of nuclear factor-\u03baB and sarco\/endoplasmic reticulum Ca(2+)-ATPase","volume":"287","author":"Park","year":"2021","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.phrs.2024.107432_bib34","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1194\/jlr.M075879","article-title":"Dietary PUFAs attenuate NLRP3 inflammasome activation via enhancing macrophage autophagy","volume":"58","author":"Shen","year":"2017","journal-title":"J. Lipid Res"},{"issue":"2","key":"10.1016\/j.phrs.2024.107432_bib35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41419-020-2322-6","article-title":"Pharmacological enhancement of TFEB-mediated autophagy alleviated neuronal death in oxidative stress-induced Parkinson's disease models","volume":"11","author":"Zhuang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2024.107432_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fncel.2020.00045","article-title":"Proteostasis of \u03b1-synuclein and its role in the pathogenesis of Parkinson's disease","volume":"14","author":"Han","year":"2020","journal-title":"Front. Cell Neurosci."},{"issue":"10","key":"10.1016\/j.phrs.2024.107432_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/biom11101508","article-title":"Mitochondrial Dysfunction, Protein misfolding and neuroinflammation in Parkinson's disease: roads to biomarker discovery","volume":"11","author":"Picca","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.phrs.2024.107432_bib38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson's disease","volume":"106-107","author":"Subramaniam","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.phrs.2024.107432_bib39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson's disease and its potential as therapeutic target","volume":"4","author":"Wang","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.phrs.2024.107432_bib40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-981-15-4272-5_2","article-title":"Autophagy and Parkinson's disease","volume":"1207","author":"Lu","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2024.107432_bib41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0278-5846(03)00019-8","article-title":"Apoptosis and Parkinson's disease","volume":"27","author":"Lev","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.phrs.2024.107432_bib42","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.bbagen.2013.12.023","article-title":"Omega-3 deficiency and neurodegeneration in the substantia nigra: involvement of increased nitric oxide production and reduced BDNF expression","volume":"1840","author":"Cardoso","year":"2014","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.phrs.2024.107432_bib43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.expneurol.2017.01.005","article-title":"Omega-3 fatty acids regulate NLRP3 inflammasome activation and prevent behavior deficits after traumatic brain injury","volume":"290","author":"Lin","year":"2017","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107432_bib44","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12974-021-02209-9","article-title":"Activation of GPR40 attenuates neuroinflammation and improves neurological function via PAK4\/CREB\/KDM6B pathway in an experimental GMH rat model","volume":"18","author":"Xiao","year":"2021","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.phrs.2024.107432_bib45","doi-asserted-by":"crossref","first-page":"11047","DOI":"10.1038\/s41598-020-68110-2","article-title":"Activation of GPR40 induces hypothalamic neurogenesis through p38- and BDNF-dependent mechanisms","volume":"10","author":"Engel","year":"2020","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.phrs.2024.107432_bib46","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2141.2011.08605.x","article-title":"CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells","volume":"153","author":"Porakishvili","year":"2011","journal-title":"Br. J. Haematol."},{"issue":"13","key":"10.1016\/j.phrs.2024.107432_bib47","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1161\/01.CIR.99.13.1685","article-title":"Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion","volume":"99","author":"Ma","year":"1999","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.phrs.2024.107432_bib48","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.devcel.2014.06.013","article-title":"TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition","volume":"30","author":"Mandell","year":"2014","journal-title":"Dev. Cell"},{"issue":"3","key":"10.1016\/j.phrs.2024.107432_bib49","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3892\/or.2012.1881","article-title":"Lysosomal membrane protein TMEM192 deficiency triggers crosstalk between autophagy and apoptosis in HepG2 hepatoma cells","volume":"28","author":"Liu","year":"2012","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.phrs.2024.107432_bib50","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/cbf.3582","article-title":"The role of Shh signalling pathway in central nervous system development and related diseases","volume":"39","author":"Li","year":"2021","journal-title":"Cell Biochem. Funct."},{"issue":"10","key":"10.1016\/j.phrs.2024.107432_bib51","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1080\/15548627.2020.1848971","article-title":"Inhibiting NLRP3 inflammasome attenuates apoptosis in contrast-induced acute kidney injury through the upregulation of HIF1A and BNIP3-mediated mitophagy","volume":"17","author":"Lin","year":"2021","journal-title":"Autophagy"},{"issue":"9","key":"10.1016\/j.phrs.2024.107432_bib52","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1158\/1078-0432.CCR-18-1474","article-title":"Activation of the lysosome-associated membrane protein LAMP5 by DOT1L serves as a bodyguard for MLL fusion oncoproteins to evade degradation in leukemia","volume":"25","author":"Wang","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"465","key":"10.1016\/j.phrs.2024.107432_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah4066","article-title":"Inflammasome inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in mice","volume":"10","author":"Gordon","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phrs.2024.107432_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115735","article-title":"The interplay between \u03b1-Synuclein and NLRP3 inflammasome in Parkinson's disease","volume":"168","author":"Huang","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"2","key":"10.1016\/j.phrs.2024.107432_bib55","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41418-018-0124-5","article-title":"MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration","volume":"26","author":"Lee","year":"2019","journal-title":"Cell Death Differ."},{"issue":"6","key":"10.1016\/j.phrs.2024.107432_bib56","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3892\/ijmm.2012.1142","article-title":"GPR40: a therapeutic target for mediating insulin secretion (review)","volume":"30","author":"Feng","year":"2012","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"10.1016\/j.phrs.2024.107432_bib57","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.immuni.2013.05.015","article-title":"Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation","volume":"38","author":"Yan","year":"2013","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.phrs.2024.107432_bib58","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.2174\/1389450117666151209122702","article-title":"GPR40 Agonists for the treatment of Type 2 diabetes mellitus: benefits and challenges","volume":"17","author":"Mohammad","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.phrs.2024.107432_bib59","first-page":"19","article-title":"Omega-3 fatty acids in primary and secondary prevention of cardiovascular diseases","volume":"84","author":"Tutor","year":"2024","journal-title":"Prog. Cardiovasc Dis."},{"key":"10.1016\/j.phrs.2024.107432_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101835","article-title":"New perspectives on randomized controlled trials with omega-3 fatty acid supplements and cognition: a scoping review","volume":"85","author":"Andriambelo","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"12","key":"10.1016\/j.phrs.2024.107432_bib61","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s40264-018-0745-0","article-title":"Correction to: liver safety of fasiglifam (TAK-875) in patients with type 2 diabetes: review of the global clinical trial experience","volume":"41","author":"Marcinak","year":"2018","journal-title":"Drug Saf."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824003773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824003773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:43:53Z","timestamp":1778795033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824003773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":61,"alternative-id":["S1043661824003773"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107432","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GPR40 agonist ameliorates neurodegeneration and motor impairment by regulating NLRP3 inflammasome in Parkinson\u2019s disease animal models","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107432"}}